Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay

Abstract Potency assessment of monoclonal antibodies or corresponding biosimilars in cell-based assays is an essential prerequisite in biopharmaceutical research and development. However, cellular bioassays are still subject to limitations in sample throughput, speed, and often need costly reagents...

Full description

Bibliographic Details
Published in:Scientific Reports
Main Authors: Stefan Schmidt, Alexander Geisel, Thomas Enzlein, Björn C. Fröhlich, Louise Pritchett, Melanie Verneret, Christian Graf, Carsten Hopf
Format: Article
Language:English
Published: Nature Portfolio 2024-09-01
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-71483-3

Similar Items